These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19147585)

  • 21. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
    Yee LD; Young DC; Rosol TJ; Vanbuskirk AM; Clinton SK
    J Nutr; 2005 May; 135(5):983-8. PubMed ID: 15867269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
    Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
    Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
    Mancini ML; Lien EC; Toker A
    Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor suppressor control of the cancer stem cell niche.
    Kramer K; Wu J; Crowe DL
    Oncogene; 2016 Aug; 35(32):4165-78. PubMed ID: 26686086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
    Davis VL; Shaikh F; Gallagher KM; Villegas M; Rea SL; Cline JM; Hughes CL
    Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.
    Cuello-Carrión FD; Cayado-Gutiérrez N; Natoli AL; Restall C; Anderson RL; Nadin S; Alvarez-Olmedo D; Castro GN; Gago FE; Fanelli MA; Ciocca DR
    Cell Stress Chaperones; 2013 Sep; 18(5):559-67. PubMed ID: 23397229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.
    Mehta RG; Peng X; Roy S; Hawthorne M; Kalra A; Alimirah F; Mehta RR; Kopelovich L
    Mol Cell Biochem; 2013 Jan; 372(1-2):249-56. PubMed ID: 23001870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.
    Yuan H; Upadhyay G; Lu J; Kopelovich L; Glazer RI
    Cancer Prev Res (Phila); 2012 May; 5(5):754-64. PubMed ID: 22427346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice.
    Manni A; Xu H; Washington S; Aliaga C; Das A; Cooper T; Richie JP; Prokopczyk B; Calcagnotto A; Trushin N; Van den Heuvel JP; Hamilton C; Demers LM; Liao J; Verderame MF; El-Bayoumy K
    Horm Cancer; 2011 Aug; 2(4):249-59. PubMed ID: 21769696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
    Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice.
    Buggiano V; Schere-Levy C; Abe K; Vanzulli S; Piazzon I; Smith GH; Kordon EC
    Int J Cancer; 2001 May; 92(4):568-76. PubMed ID: 11304693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal adipocyte PPARγ protects against breast tumorigenesis.
    Skelhorne-Gross G; Reid AL; Apostoli AJ; Di Lena MA; Rubino RE; Peterson NT; Schneider M; SenGupta SK; Gonzalez FJ; Nicol CJ
    Carcinogenesis; 2012 Jul; 33(7):1412-20. PubMed ID: 22581835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PPARγ agonist efatutazone increases the spectrum of well-differentiated mammary cancer subtypes initiated by loss of full-length BRCA1 in association with TP53 haploinsufficiency.
    Nakles RE; Kallakury BV; Furth PA
    Am J Pathol; 2013 Jun; 182(6):1976-85. PubMed ID: 23664366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the activator protein 1 transcription factor for the prevention of estrogen receptor-negative mammary tumors.
    Shen Q; Uray IP; Li Y; Zhang Y; Hill J; Xu XC; Young MR; Gunther EJ; Hilsenbeck SG; Colburn NH; Chodosh LA; Brown PH
    Cancer Prev Res (Phila); 2008 Jun; 1(1):45-55. PubMed ID: 19138935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.
    Kumar R; Balasenthil S; Pakala SB; Rayala SK; Sahin AA; Ohshiro K
    Cancer Res; 2010 Aug; 70(16):6598-608. PubMed ID: 20710043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
    Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
    Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.